JBT Marel Corporation (JBTM) Earnings: Q3 2026 Results

The quarter ended September 30, 2026 and JBT Marel published the results on November 3, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. JBT Marel reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• JBT Marel realigned its reportable segments in the fourth quarter of 2025 into Protein Solutions and Prepared Food and Beverage Solutions, and recast 2025 segment revenue to match.
• Since 2026 JBT Marel's release prints figures in whole millions; its 2025 releases printed one decimal (Q3 2025 revenue was $1,001.3 million as first reported).

Source: JBT Marel Q3 2026 results, November 3, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How JBT Marel splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• JBT Marel's Protein Solutions revenue was $469 million in Q3 2026, up 6% from $441 million in Q3 2025, 47% of total revenue.
• JBT Marel's Prepared Food and Beverage Solutions revenue was $525 million in Q3 2026, down 6% from $560 million in Q3 2025, 53% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

JBT Marel's full-year 2026 guidance table: revenue $3,950 million to $4,000 million, net income margin 5.6% to 6.0%, adjusted EBITDA margin 17.25% to 17.50%, GAAP diluted EPS $4.30 to $4.60 and adjusted EPS $8.10 to $8.40.

In its Q3 2026 release, JBT Marel said:

“JBT Marel is refining its full-year 2026 revenue, net income, and adjusted EBITDA guidance to primarily reflect lower third quarter book-and-ship revenue and revised fourth quarter expectations for the Diversified Food and Health business within the Prepared Food and Beverage Solutions segment.”

“For the full year 2026, JBT Marel expects year-over-year consolidated revenue growth of approximately 5 percent at the midpoint, which is inclusive of approximately 1.5 percent foreign exchange translation benefit.”

“The full year tax rate is estimated to be approximately 23 percent.”

Source: JBT Marel Q3 2026 release, Nov 3, 2026.

This is the company's own guidance as of Nov 3, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the JBTM forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP revenue and diluted EPS (net income), each as first reported in that quarter's release.

We do not hold a confirmed date for JBT Marel's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 3, 2026

JBT Marel, formed when John Bean Technologies acquired Iceland's Marel hf. on January 2, 2025, sells food and beverage processing equipment and services through two segments. Protein Solutions covers initial processing of poultry, pork, fish and beef (cut-up, bone detection and removal, portioning, robotic batching). Prepared Food and Beverage Solutions covers downstream preparation, preservation and packaging, plus pet food, dairy, bakery, pharmaceutical and warehouse automation markets. (JBT Marel Form 10-K, 2025, Mar 2, 2026)

JBT Marel's Q3 2026 revenue was $994 million, down 1 percent from $1,001 million. Protein Solutions rose 6.3% to $469 million, mainly on higher volumes in the Poultry business. Prepared Food and Beverage Solutions fell 6.3% to $525 million because of lower volumes in its Diversified Food and Health business, where JBT Marel cited softer CPG-related book-and-ship volume. Revenue was below JBT Marel's own expectations for that reason. (JBT Marel Q3 2026 release, Nov 3, 2026; JBT Marel Form 10-Q, Q3 2026, Nov 3, 2026)

About half of JBT Marel's revenue is recurring: aftermarket parts and services, rebuilds, equipment leases and subscription software. Recurring revenue was $239 million in Protein Solutions and $263 million in Prepared Food and Beverage Solutions, against $230 million and $262 million of non-recurring revenue from new equipment, installation and software licenses. The 10-Q credits a favorable mix of recurring revenue for part of the adjusted EBITDA margin gain. (JBT Marel Form 10-Q, Q3 2026, Nov 3, 2026)

By the region where the end customer resides, Europe, the Middle East and Africa supplied $228 million of Protein Solutions revenue and $175 million of Prepared Food and Beverage Solutions revenue, and the U.S. and Canada $152 million and $250 million. Asia Pacific Prepared Food and Beverage revenue fell to $42 million from $73 million a year earlier. (JBT Marel Form 10-Q, Q3 2026, Nov 3, 2026)

JBT Marel's inbound orders were $976 million in the quarter, against $946 million a year earlier, and the order backlog was $1,516 million, against $1,339 million. The 10-Q puts remaining performance obligations at $1.5 billion, with 40% to 45% expected to be recognized in 2026 and 50% to 55% in 2027. (JBT Marel Q3 2026 release, Nov 3, 2026; JBT Marel Form 10-Q, Q3 2026, Nov 3, 2026)

JBT Marel's GAAP diluted EPS was $1.34, against $1.26, and adjusted EPS $2.19, against $1.94. Adjusted income of $113 million adds back $39 million of acquisition related amortization and depreciation, $9 million of M&A related costs, $7 million of restructuring costs and $3 million of debt issuance cost amortization, less a $15 million tax effect. (JBT Marel Q3 2026 release, Nov 3, 2026)

JBT Marel's interest expense, net fell to $13 million from $21 million, which the 10-Q attributes to lower debt, a more favorable debt mix and net investment hedges. The effective tax rate was 20.5%, against 20.4%, and included a $2 million discrete benefit from finalizing prior-year tax return positions. (JBT Marel Q3 2026 release, Nov 3, 2026; JBT Marel Form 10-Q, Q3 2026, Nov 3, 2026)

JBT Marel's diluted shares were 51.6 million, against 52.3 million. It repurchased about 800,000 shares for $94 million in the quarter, and on October 30, 2026 its board added $500 million to the buyback, bringing the authorization to $700 million. (JBT Marel Q3 2026 release, Nov 3, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

JBT Marel publishes a full-year guidance table in its release. With the Q3 2026 report it set 2026 revenue at $3,950 million to $4,000 million, citing lower third-quarter book-and-ship revenue and lower fourth-quarter expectations for Diversified Food and Health, and raised the midpoint of its margin and EPS guidance. The table calls for an adjusted EBITDA margin of 17.25% to 17.50%, GAAP diluted EPS of $4.30 to $4.60 and adjusted EPS of $8.10 to $8.40. (JBT Marel Q3 2026 release, Nov 3, 2026)

The guidance assumes about $168 million of acquisition related amortization and depreciation, $33 million of M&A related costs, $24 million of restructuring costs, interest expense of about $46 million and a full-year tax rate of about 23 percent. JBT Marel expects revenue growth of about 5 percent at the midpoint, including about 1.5 percent from foreign exchange. (JBT Marel Q3 2026 release, Nov 3, 2026)

A consensus figure is the average of the models published by the analysts who cover JBT Marel, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones JBT Marel's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning JBTM is on is JBTM a buy or a sell?, what analysts expect next is on the JBTM forecast, and what the company does is on the JBT Marel Corporation (JBTM) stock page.

Every number on this page can be traced to a document JBT Marel published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.